Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine adjunct analgesia in opium users undergoing open heart surgery
IRCT20230603058373N1Phase 4Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine in postoperative delirium (POD) and arrhythmia, sponsored by Semnan University of Medical Sciences. Primary endpoints: Postoperative delirium, Cognitive function and 2 more. Started Dec 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)arrhythmia
Beyond the preview
Go deeper on IRCT20230603058373N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230603058373N1.